Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Peptobiotics runs a Biotechnology Research operation from Singapore. Privately held, at peptobiotics.com. It holds one address on record, all in Singapore. It employs 22 people, on the record. It lists synthetic biology and livestock health among its specialties. One Singapore registration (UEN) is a confirmed match. The latest round on record is Series A at US$6.2M. The record links eight similar brands, most of them in Biotechnology Research.
UEN202013648C
| PEPTOBIOTICS PTE. LTD. | UEN 202013648C |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Livestock disease prevention and sustainable agri productivity. Singaporean synbio startup funded by EF Venture Capital.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 3 |
|---|---|
| Axis | 2024 to 2026 |
| Series A · 9 May 2024 | US$ 6.2M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Singapore entity on ACRA: PEPTOBIOTICS PTE. LTD. (UEN 202013648C), high confidence.
22 counted staff profiles at January 2026, above the self-reported 2–10 band.
One address on record, Singapore only. Primary: 21 Biopolis Road, #05-01, Singapore 138567.
Three rounds. Latest 9 May 2024: Series A, US$6,200,000, investor Hatch Blue Ltd.
One tag on the brand's own list, among them synthetic biology and livestock health.
Eight peer profiles on record: Nuevocor and BluMaiden Biosciences.